Windgap Medical Profiled on ‘Drug Development & Delivery’ Website

Published on drug-dev.com

Windgap Medical offers drug delivery devices that simplify, auto-mate, and accelerate the administration of complex injectables.

With our patient-centric design approach, our products are designed to manage the challenges of reconstitution, liquid/liquid mixing, and sequential delivery of multiple liquid drugs. By reducing the number of user steps, our products fit easily into a patients’ daily life, enhancing usability and adherence.

Windgap’s injection devices are ideal for:

  • mAbs and other biologics

  • Long acting Injectables

  • Lyophilized drugs and suspensions

  • High viscosity liquids (up to 5000+cP)

  • Large volume injections (up to 10mL)

In partnership with pharmaceutical companies, we leverage our enhanced product features to improve outcomes for your life-changing molecules.

CORE CAPABILITIES

Mixing: Our automated approach to fluid management enables active, in device-controlled, mixing that eliminates shaking and swirling from the instructions for use. We provide a reliable end- point that ensures a lyophilized (or powdered) drug is mixed the same way, every single time.

Multi-Liquid Delivery: In two simple steps, we can administer two liquid drugs through the same delivery needle. The perfect platform for drugs that can’t be co-formulated in the same container.

PRODUCT PLATFORMS

LVDC (Large Volume Dual Chamber) Platform

The novelty of Windgap’s LVDC platform stems from its innovative arrangement of standard off-the-shelf primary drug containers (PDC). The PDC architecture features side-by-side nesting of two, readily available, single-chamber cartridges with Windgap’s proprietary mixing and delivery needle hub. The side-by-side nesting permits use of ISO- compliant cartridges compatible with industry-standard filling methods, while maintaining a compact, easy-to-handle form factor.

The cartridges can be either plastic or glass; cartridge sizes from 1mL to 5mL. The design is compatible with standard aseptic filling methods or terminal sterilization strategies; and IM or SC needle lengths.

ANDI (Automatic recoNstitution Dual Chamber Injector) Platform

This offers a revolutionary twist on emergency autoinjectors. This compact device provides a thermally stable SC/IM drug delivery platform for automatic mixing and rapid dissolution of delivered doses up to 0.3 mL. ANDI is designed to meet the 99.999% reliability metrics for rescue applications. Windgap’s first combination product, the ANDIpen®, is being commercialized in partnership with ALK-Abelló to deliver emergency IM epinephrine doses.

INJECT SIMPLICITY™ INTO YOUR NEXT COMBINATION PRODUCT

Reach out to discuss your molecule’s unique needs and opportunities to collaborate via partnership or feasibility studies.

You focus on the formulation. We’ll deliver the solution.

Previous
Previous

Challenging the “3R” Rhetoric in the Autoinjector Industry

Next
Next

In The Thick Of It: Accelerating The Mixing And Delivery Of High-viscosity Injectables